Fate's tissue regeneration proteins validated in vivo

Posted by Leanne Kodsman on

San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its Wnt protein therapeutic program, in development for use in skeletal muscle regeneration, has moved several steps closer to its goal.

After dealing with manufacture, formulation and delivery issues, Fate now has a selection of candidate proteins and has validated their therapeutic potential in a number of preclinical animal models. Naturally occurring proteins in the Wnt family are involved in stem cell fate and tissue development and repair.


San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its Wnt protein therapeutic program, in development for use in skeletal muscle regeneration, has moved several steps closer to its goal.

After dealing with manufacture, formulation and delivery issues, Fate now has a selection of candidate proteins and has validated their therapeutic potential in a number of preclinical animal models. Naturally occurring proteins in the Wnt family are involved in stem cell fate and tissue development and repair.

Fate's FT301 program includes a number of proprietary Wnt7a-based protein therapeutics that are in development for the regeneration of skeletal muscle by modulating stem cells. In August,Fate snagged 9.2 million of equity financing, but the specific programs that this will support have not been disclosed.

The company also said it has strengthened its advisory team by adding K. Christopher Garcia of Stanford University School of Medicine, the researcher who published the first molecular structure of a Wnt protein.


    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

And the winner is...
It is now time to announce that the $10,000 Grant for Post-Doctorate Research in the Li...
Read the Article
NEW! Synthetic CSF Now Available
Synthetic Human Cerebrospinal Fluid (CSF) from Innovative Research has been prepared us...
Read the Article
ASSURED FLOW SOLUTIONS PARTNERS WITH INNOVATIVE RESEARCH TO DEVELOP TEST KITS TO HELP IN COVID-19 FIGHT
HOUSTON—10 April 2020 Assured Flow Solutions (AFS) is teaming up with Innovative Resear...
Read the Article

← Older Post Newer Post →